Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

On this page

Definition & Epidemiology - Prostate's Prime Problem

  • Definition: Benign Prostatic Hyperplasia (BPH): non-malignant prostate enlargement.
    • Involves stromal & epithelial cell proliferation.
    • Mainly in periurethral (transition) zone; can cause Bladder Outlet Obstruction (BOO).
  • Epidemiology:
    • Age-related: prevalence ↑ significantly with age.
    • Dihydrotestosterone (DHT) is a key hormonal mediator.
    • Affects >50% of men by age 60.

    ⭐ BPH is primarily a disease of aging men; histological prevalence approaches 90% by age 85.

Pathophysiology & Anatomy - Growth Zone Gumbo

  • Non-malignant stromal & epithelial cell proliferation.
  • Primarily in transition zone (periurethral), leading to bladder outlet obstruction (BOO).
  • Hormonal basis: Androgenic stimulation (DHT primary driver).
    • Imbalance: ↑ Estrogen/Androgen ratio with age may contribute.

⭐ Dihydrotestosterone (DHT), converted from testosterone by 5-alpha reductase type 2, is the primary androgen stimulating prostatic growth in BPH, predominantly in the transition zone. Prostate anatomy and BPH histologyoka

Clinical Features - LUTS Alert Level

  • Lower Urinary Tract Symptoms (LUTS) are key:
    • Voiding (Obstructive) Symptoms:
      • Weak stream
      • Straining
      • Hesitancy
      • Intermittency
      • Incomplete emptying
      • Terminal dribbling
    • Storage (Irritative) Symptoms:
      • Frequency
      • Urgency
      • Nocturia
      • Urge incontinence

⭐ The International Prostate Symptom Score (IPSS) is a crucial tool for quantifying LUTS severity and guiding BPH management decisions. Mild: 0-7, Moderate: 8-19, Severe: 20-35.

  • Digital Rectal Examination (DRE): May reveal smooth, firm, elastic enlargement of the prostate (size on DRE correlates poorly with LUTS severity).

Investigations - Detective Work DRE

  • Size & Symmetry: Assess for enlargement (e.g., Grade I-IV); typically symmetrical.
  • Consistency: Firm, smooth, elastic (rubbery feel, like tip of nose). Avoids stony hard (CaP).
  • Surface: Regular, without discrete hard nodules or areas of induration.
  • Median Sulcus: Often shallow, indistinct, or completely obliterated by enlargement.
  • Tenderness: Usually absent. If present, consider prostatitis.
  • Anal Sphincter Tone: Routinely checked during examination.

⭐ On DRE, BPH typically presents as a symmetrically enlarged, firm, smooth, and elastic prostate with an obliterated median sulcus.

Treatment Strategies - Flow & Freedom Fixes

  • Watchful Waiting: Mild symptoms (IPSS < 8).
  • Medical Management:
    • α-blockers (Relax smooth muscle): Tamsulosin, Alfuzosin, Silodosin. Rapid onset.
      • Side effects: Postural hypotension, ejaculatory dysfunction (esp. Silodosin).
    • 5α-reductase inhibitors (5-ARIs) (Reduce prostate size): Finasteride, Dutasteride. Slow onset (3-6 months).
      • Side effects: ↓ libido, erectile dysfunction, ↓ PSA.
    • Combination therapy (α-blocker + 5-ARI): For LUTS with demonstrable prostatic enlargement & risk of progression.
    • Antimuscarinics (e.g., Tolterodine, Solifenacin): For predominant storage symptoms, if PVR low.
    • PDE-5 inhibitors (e.g., Tadalafil): For BPH-LUTS with/without ED.
  • Surgical Management: Moderate-severe symptoms, complications (AUR, stones, renal impairment).
*   Transurethral Incision of the Prostate (TUIP): Smaller prostates (<**30g**), no median lobe.
*   Minimally Invasive Surgical Therapies (MISTs): UroLift, Rezum (steam ablation).

⭐ Transurethral Resection of the Prostate (TURP) remains the gold standard surgical treatment for moderate to severe BPH, though newer minimally invasive options like Holmium Laser Enucleation of the Prostate (HoLEP) are gaining popularity.

📌 Mnemonic (TURP Complications): "Bleeding, Urethral stricture/ UTI, Retrograde ejaculation, Perforation, TUR syndrome" (BUT RPT is better: Bleeding, UTI/Stricture, Transfusion, Retrograde Ejaculation, Perforation, TUR Syndrome).

High‑Yield Points - ⚡ Biggest Takeaways

  • BPH, most common benign tumor in men, affects the transitional zone.
  • Dihydrotestosterone (DHT) is the primary hormonal stimulus for growth.
  • IPSS assesses symptom severity; uroflowmetry shows ↓ peak flow.
  • Alpha-blockers (e.g., Tamsulosin) provide rapid symptom relief.
  • 5-alpha-reductase inhibitors (e.g., Finasteride) reduce prostate volume.
  • TURP is the gold standard surgery for moderate-severe BPH.
  • Watch for acute urinary retention, recurrent UTIs, bladder stones as complications.

Practice Questions: Benign Prostatic Hyperplasia

Test your understanding with these related questions

Which of the following drugs can decrease the size of the prostate?

1 of 5

Flashcards: Benign Prostatic Hyperplasia

1/10

PCNL is indicated in the following condition:If the renal stone is _____ stone as it is associated with urinary tract infection.

TAP TO REVEAL ANSWER

PCNL is indicated in the following condition:If the renal stone is _____ stone as it is associated with urinary tract infection.

struvite

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial